Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...
Gemini 2.5 Pro Experimental boosts accuracy by reasoning before responding, available in Google AI Studio and for Gemini ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Pharmaceutical Technology on MSN9h
Google-backed Isomorphic Labs raises $600m to advance AI drug discoveryThe funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
As Google attempts to catch up to OpenAI’s ChatGPT, its DeepMind artificial intelligence unit is in a near constant state of ...
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback